INTRODUCTION {#SEC1}
============

The genetic variability of rapidly evolving viruses, such as HIV, can eventually cause established assays to underestimate the prevalence of the virus in a population, the load of the virus in a patient, or even the very presence of the virus in a patient. Mutations in regions that bind to primers and probes lower their affinities and could eventually prevent their binding entirely ([@B1]). Related to our long-standing interest to develop assays to detect pathogenic viruses with genetic variability ([@B4],[@B5]), we were interested in evaluating various strategies to overcome these problems.

One strategy simply creates multiple primers that perfectly match all conceivable variants in a population ([@B6]), either by explicit synthesis of multiple primers, or by using mixtures of phosphoramidites when adding a nucleotide at an ambiguous site ([@B7]). However, each level of added diversity dilutes the perfectly matched primer, creates opportunities for off-target amplification, and reduces assay sensitivity. Further, even with these strategies, medically relevant drug-resistance mutations embedded in a segment of a target that contains irrelevant variability can rapidly become difficult to detect ([@B3]).

An alternative strategy to manage target sequence diversity uses a 'universal nucleobase', a synthetic nucleotide in a primer that can pair with all natural nucleobases at its binding site ([@B8],[@B9]). A large body of literature covers many clever designs for universal nucleobases ([@B10]). In practice, however, inosine is common as a universal base, notwithstanding some problematic aspects of its behavior ([@B13],[@B14]). Because of these, no single analog can be considered to be truly universal ([@B15],[@B16]).

True universality is, however, not always needed (or even desired) for biological applications. First, if too many universal nucleotides are added to a probe, the resulting molecule may have too many places to bind off-target in a complex DNA sequence background. Further, when seeking to manage a naturally divergent sequence, evolutionary analyses often find that transition mutations (replacing a purine by a purine, or a pyrimidine by a pyrimidine) are more common than transversions (replacing a purine by a pyrimidine, or a pyrimidine by a purine) in coding and non-coding regions ([@B17],[@B18]). In these cases, biversality (binding to either purine, or to either pyrimidine, but not to both purines and pyrimidines) may be preferred over universality, managing the more common ambiguity without creating the excessive off-target binding.

Tautomerism is one strategy to create biversality. For example, Brown and his coworkers made candidate biversals by exploiting the tautomerization of oximes ([@B19]). Their pyrimidine biversal used the oxime-alkoxyamine tautomerization of N6-methoxycytidine ([@B20]); here, the oxime tautomer is hydrogen-bond complementary to A, while the enamine tautomer is complementary to G (Figure [1](#F1){ref-type="fig"}). Their corresponding purine biversal exploited oxime-alkoxyamine tautomerization in a purine ring with N6-methoxydiaminopurine ([@B21],[@B22]); the oxime tautomer is hydrogen-bond complementary to C, while the alkoxyamine tautomer is complementary to T (Figure [2](#F2){ref-type="fig"}).

![Two candidate pyrimidine biversal nucleoside analogs that exploit oxime-alkoxylamine tautomerism. A second generation biversal nucleoside (**P~C~** and **P~T~**, right) showed better pairing to G/A than the first generation biversal nucleoside (**P**, left), presumably because the appended CH~3~O- group in the first species can swing around to a '*cis*' conformation that may obstruct nucleobase pairing.](gky392fig1){#F1}

![Two candidate purine biversal nucleosides. In the purine biversal nucleoside reported by Brown (**K**, left), the appended CH~3~O- group can swing to a '*cis*' conformation that may obstruct base pairing with either T or C. In the new candidate purine biversal reported here (**H**, right), this cannot happen. However, the additional ring may influence the tautomer ratio, based on geometries of substituents attached to double bonds.](gky392fig2){#F2}

In Brown's pyrimidine biversal, the methoxy group is 'tied back' as shown in **P~C~** and **P~T~** (right in Figure [1](#F1){ref-type="fig"}). Without the tie-back, rotation of the methoxy group can obstruct biversal **P** pairing with G and A (left in Figure [1](#F1){ref-type="fig"}). Because of the nitrogen at position 7, purines themselves do not offer any ready position to tie back the exocyclic N-O unit (Figure [2](#F2){ref-type="fig"}, left). Thus, in the classical purine biversal systems, the melting temperatures are lower, presumably because the methoxy group in a '*cis*' conformation interferes with hydrogen bonding to the Watson--Crick complement.

We approached the purine biversal problem by synthesizing a tricyclic analog based on a 7-deazapurine, whose carbon allows for a point of attachment of the ring. This should have electronic properties similar to the conformationally flexible oxime. Brown and his coworkers attempted to make a purine analog, but without reporting success ([@B23],[@B24]).

Here, we report successful synthesis of a tricyclic purine biversal with the alkoxyl substituent 'tied back'. We then report biophysical data that compare binding of oligonucleotides containing various biversal analogs to complementary and semi-complementary oligonucleotides. We follow with results from polymerase chain reaction (PCR) amplification supported by primers containing these biversals, and ligation architectures to detect single nucleotide polymorphisms (SNPs) using probes having various numbers of these biversals.

MATERIALS AND METHODS {#SEC2}
=====================

Oligonucleotide {#SEC2-1}
---------------

Oligonucleotides were synthesized in 1.0 μmol scale using the recommended protocol for an ABI 394 DNA synthesizer, with extended coupling time (10 min) for the tricyclic purine biversal **H**. All natural (A, G, C and T) ultramild phosphoramidites were from Glen Research. Oligonucleotides were cleaved from solid support and deprotected by treatment with 0.05 M K~2~CO~3~ in MeOH (0.2 ml, 55°C overnight). The deprotection mixture was diluted with 1 M TEAA (0.4 ml), desalted by Sep-Pak C18 cartridge (Waters) and purified by ion exchange high-performance liquid chromatography (HPLC, Dionex DNAPac PA-100 22 × 250 mm Prep column, eluent A = 25 mM NaOH + 0.1 M NaCl, eluent B = 25 mM NaOH + 1 M NaCl, from 10 to 50% B in 30 min, flow rate 10 ml/min). The appropriate fractions were collected, neutralized by aqueous acetic acid, desalted by Sep-PaK and lyophilized. The purity of each oligonucleotide was analyzed by ion exchange HPLC (traces in [Supplementary Data](#sup1){ref-type="supplementary-material"}). DNA with only natural nucleobases was obtained from Integrated DNA Technologies (IDT), Coralville, IA, USA.

Melting temperature analysis {#SEC2-2}
----------------------------

Oligonucleotides were combined in equimolar concentrations (1 μM) in buffer (0.1 M NaCl, 0.02 M sodium cacodylate pH 7.0). Absorbance of each solution was monitored at 260 nm over a temperature range from 20°C to 85°C with a ramp rate of 0.5°C/min. Melting curves were measured on a Shimadzu UV spectrophotometer UV-1800 with a thermal Peltier cell block and temperature probe.

Sanger sequencing of the PCR products generated with 3H- and 4H-containing primers {#SEC2-3}
----------------------------------------------------------------------------------

Wild-type (WT) DNA template was amplified by standard primers, 3H- or 4H-containing primers (1 μM of each primer) in 1× AmpliTaq Gold reaction buffer (15 mM Tris--HCl, 50 mM KCl, pH 8.3 at 25°C), MgCl~2~ (3 mM), dNTPs (each 0.2 mM) and 2.5 units of Hot Start AmpliTaq Gold DNA polymerase (5 U/μl, ABI, total 25 μl). PCR: initially at 95°C for 10 min; followed by 35 cycles (95°C for 10 s, 50°C for 30 s, 72°C for 30 s); finally 72°C for 5 min. Upon completion, samples (10 μl) were mixed with 6× agarose loading dye (2 μl, Promega) and analyzed on 3% agarose gel.

PCR products (2 μl) were cloned (pCRTM4-TOPO^®^) using TOPO TA Cloning Kit (Invitrogen) and transformed into One Shot^®^ TOP10 competent cells following manufacturer's instruction. Blue-white screens gave 32 colonies that were sequenced (BioBasic). The sequencing results are shown in [Supplementary Table S1 and Figure S1](#sup1){ref-type="supplementary-material"}.

Comparison of the amplification efficiency of 3H-, 4H-, 4K-, and 4I-containing primers using real-time PCR {#SEC2-4}
----------------------------------------------------------------------------------------------------------

WT templates (3 × 10^6^ and 3 × 10^4^ copies of WT-90) and divergent templates (3 × 10^6^ and 3 × 10^4^ copies of Div4-90) were obtained from IDT and amplified in 1× AmpliTaq Gold buffer (15 mM Tris--HCl, 50 mM KCl, pH 8.3 at 25°C), with MgCl~2~ (3 mM), dNTPs (each 0.2 mM), Hot Start AmpliTaq Gold DNA polymerase (2.5 units, 5 U/μl, ABI), and EvaGreen^®^ dye (0.2 × Biotium) using five types of primers (standard, 3**H**-, 4**H**-, 4**K**-, and 4**I**-containing primers, Table [2](#tbl2){ref-type="table"}), respectively. PCRs and no template control (NTC) were performed in replicates under identical conditions: 95°C for 8 min, followed by 40 cycles (95°C for 10 s, 50°C for 30 s, 72°C for 30 s) in the Roche LightCycler^®^ 480 real-time PCR system. LightCycler^®^ 480 software was used to calculate threshold cycle (*C*~t~) and *T*~m~. Upon completion of PCR, each sample (10 μl) was mixed with 6× agarose loading dye (2 μl, Promega) and analyzed on agarose gel (3%) electrophoresis (Figure 3; [Supplementary Figures S2 and S3a](#sup1){ref-type="supplementary-material"}).

General protocol for the ligation assay {#SEC2-5}
---------------------------------------

A mixture (15 µL) of ^32^P-labeled acceptor probe (100 nM), donor probe (5′-phosphorylated, 100 nM), and target (100 nM) in 1× ligation buffer was first heated at 90°C for 1 min in a Bio-Rad Thermal Cycler, then, cooled to 45°C with a ramp rate of 0.2 °C/second (unless stated otherwise). 5 µL of Taq DNA Ligase (40 U/assay) in 1× ligation buffer was added to the above mixture at 45 °C. Each ligation assay (20 μL) was incubated at 45°C for 5, 20, or 60 min. Aliquots (7 μl) were quenched with 7 µL of loading dye (95% of formamide with 10 mM ethylenediaminetetraacetic acid) and resolved by polyacrylamide gel electrophoresis (20% PAGE, 7 M urea). (Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}; [Supplementary Figures S4a and S4b](#sup1){ref-type="supplementary-material"}).

RESULTS AND DISCUSSION {#SEC3}
======================

Nucleoside and oligonucleotide synthesis {#SEC3-1}
----------------------------------------

The synthesis plan sought the tricycle **1** via intramolecular closure of **2**, made by displacement of chloride by hydroxylamine. That ring could have either one (*n* = 1) or two (*n* = 2) CH~2~ units. In either, the leaving group for compound **3** might arise from an alcohol in **4**, available from a vinyl unit if *n* = 1 and from an allyl unit if *n* = 2 (Scheme [1](#F6){ref-type="fig"}). Both were made, but only the tosylate and mesylate with *n* = 2 proved to be satisfactory.

![Retrosynthetic strategy for biversal tricyclic purine nucleoside.](gky392fig6){#F6}

Thus, a new synthesis began by converting **5** (Scheme [2](#F7){ref-type="fig"}) to an alcohol that was mesylated to give **7** ([@B25]). The chloride in **7** was displaced by hydroxylamine followed by cyclization of **8** with potassium tert-butoxide in DMF; the reaction failed when THF was used as solvent.

![Synthesis of biversal tricyclic purine nucleoside **10** and phosphoramidite **13**.](gky392fig7){#F7}

The product from cyclization, after being purified by chromatography, was treated with methanolic NH~3~ at 25°C to give analytically pure **9**, confirmed by ^1^H and ^13^C nuclear magnetic resonance (NMR) and high-resolution mass spectrometry (HRMS). Removal of the pivaloyl group in NH~3~ at 55°C gave deprotected tricyclic nucleoside **10**, confirmed by NMR and HRMS. The UV of **10** shows two maxima (270, 301 nm), assigned to the imine and alkoxylamine tautomers.

Protected phosphoramidite **13** made from **9** (Scheme [2](#F7){ref-type="fig"}) was used for solid phase DNA synthesis. Deprotection in concentrated NH4OH at 55°C overnight gave side-reactions. Successful deprotection was achieved by K~2~CO~3~ (0.05 M) in MeOH (55°C overnight) to give oligonucleotides with 2--4 tricyclic purine nucleosides (**H**) easily resolved by HPLC (Tables [1](#tbl1){ref-type="table"}--[4](#tbl4){ref-type="table"}).

###### Melting temperatures of duplexes modified with purine analogs
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###### Primers and targets used in PCR
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###### Ligation probes with biversal purine
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###### Ligation probes with biversal purine for SNP detection
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Thermal stability {#SEC3-2}
-----------------

For hybridization, complementary oligos with all possible nucleotides at the biversal pairing site were synthesized. For comparison, oligos containing first-generation purine biversal nucleobase (**K**, Glen Research), **H**, **I**, and natural A and G in the same position were synthesized (Table [1](#tbl1){ref-type="table"}).

The first set of denaturation experiments (Table [1](#tbl1){ref-type="table"}) reproduce Brown\'s results with his first generation purine biversal **K**. Consistent with his reports, **K** showed biversality and specificity. The *T*~m~ values of duplexes containing two or three **K**:T pairs were only slightly higher than those with **K**:C pairs. The values of duplexes with purine:purine **K**:G and **K**:A mismatches were lower; the Δ*T*~m~ was ∼2°C per substitution. *T*~m~ values of **K**:C and **K**:T were much lower than the values of duplexes containing the natural pairs (G:C and A:T), also consistent with Brown's reports.

**H** was biophysically better by some metrics. Thus, the *T*~m~ of duplexes containing **H**:T pairs were almost the same as those of duplexes containing A:T pairs, which were higher than the same duplexes with **K**:T pairs by ∼2.3°C per substitution. The **H**:C pair had *T*~m~s similar to those with **K**:C pairs. However, context variability was large. In duplexes with two central X:Y pairs, the *T*~m~ with **H**:C pairs was 3°C higher than with **K**:C pairs, while in duplex with two end X:Y pairs, the *T*~m~ of **H**:C pairs was 2°C lower than the *T*~m~ of **K**:C pairs. With three substitutions pairing with C, no preference of **H** over **K** was seen (Table [1](#tbl1){ref-type="table"}).

**H** displayed less biversality in these studies. The difference in *T*~m~s of **K** paired with T versus C was only ∼0.7°C per substitution, T being the preferred partner for **K**. In contrast, the preference of **H** for T over C was ∼3°C per substitution. This implies that **H** resembles adenine more than guanine. This parallels its enzymatic properties (see below); **H** is more 'enamine' than 'oxime'.

This can be rationalized. Double bonds force attached atoms to lie in a plane. In the enamine tautomer complementary to T, the moving double bond lies in a 6-ring (**H~A~**, Figure [2](#F2){ref-type="fig"}, right), which is naturally planar. However, in the oxime tautomer complementary to C (**H~G~**, Figure [2](#F2){ref-type="fig"}, right), this double bond is part of a 7-ring where its substituents (including oxygen) strain to be planar (Figure [2](#F2){ref-type="fig"}). These geometric factors may account for the preference of **H** for T, compared with a smaller preference of **K**.

However, **H** in some *T*~m~ studies behaved more like a 'universal' base than a 'biversal' base. Thus, *T*~m~ values of duplexes with two or three **H**:G mismatches were similar to those with two or three **H**:C matches. The *T*~m~ of the **H**:A mismatch was lower than the *T*~m~ of **H**:C by only ∼0.7°C per pair. In summary, **H**:T (by 2.4°C per pair) \> **H**:G (by 0.6°C per pair) \> **H**:C (by 0.7°C per pair) \> **H**:A. Further, duplexes with two or three **H**:G mismatches were more stable than **K**:G mismatches (∼2.7°C per pair); and the **H**:A pair was more stable than **K**:A (∼0.6°C per pair).

The thermal stability of duplexes where **H** is paired with all natural bases was further compared to the stability of duplexes having inosine (**I**) at the corresponding sites. Overall, **I**:C matches have the same stability as **H**:T matches, duplexes containing two or three **I**:A pairs were more stable than **H**:A mismatches (∼2.6°C per pair), and the **I**:G pair was less stable than **H**:G (∼0.6°C per pair). In summary **I**:C (by 1.1°C per pair) \> **I**:A (by 2°C per pair) \> **I**:T ≈ **I**:G.

Biversal H supports PCR {#SEC3-3}
-----------------------

We then asked whether DNA containing **H** could prime on DNA/RNA templates. Results with **K** were consistent with results from Brown ([@B26]). Primers targeted the consensus segments of the reverse transcriptase gene of HIV-1B. Biversal **H**'s or **K**'s replaced three or four As in primers at sites known to have high divergence. The WT sequence was taken from the consensus. The divergent target had transition mutations of A to G and T to C in forward and reverse primer binding regions (Table [2](#tbl2){ref-type="table"}).

Amplicons from PCR were resolved by agarose gel electrophoresis ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Both 3**H**- and 4**H**-primers gave clean, full-length amplicons at rates similar to rates of amplicon generation with perfectly matched standard primers. This showed that **H**-containing primers efficiently hybridize with the WT targets, consistent with the biophysical studies. Further, these results showed that Taq DNA polymerase can use biversal **H**-containing DNA as a template, incorporating a standard dNTP opposite **H** to support the PCR ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

PCR products from 3**H**- and 4**H**-primers were cloned and sequenced ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Results showed that biversal **H** directed incorporation of dTTP 95% of the time, and dCTP 5% of the time. In contrast, Brown's biversal **K** directed incorporation of dTTP 87% the time and dCTP 13% of the time (26). The statistics are not large enough to draw conclusions about the influence of context on selectivity.

Management of sequence divergence in PCR amplification {#SEC3-4}
------------------------------------------------------

To evaluate the ability of biversal-containing primers to amplify targets with mutations, a target that had diverged at four sites, replacing A's by G's in one and T's by C's in another, was probed in two concentrations ('Hi' = 3 × 10^6^ copies; 'Lo' = 3 × 10^4^ copies); a consensus 'WT' target (3 × 10^6^ or 3 × 10^4^ copies of WT-90) was added to a PCR reaction mixture. Standard primers with four A:C mismatches were used to illustrate the value of the biversal primers (Table [2](#tbl2){ref-type="table"}). Amplicons were resolved by electrophoresis (Figure [3A](#F3){ref-type="fig"}).

![(**A**) PCR assays using standard primer or biversal 4H- and 4K-containing primers. Lanes 1, 6 and 11: 3 × 10^6^ copies of WT target. Lanes 2, 7 and 12: 3 × 10^4^ copies of WT target. Lanes 3, 8 and 13: 3 × 10^6^ copies of divergent target (Div4). Lanes 4, 9 and 14: 3 × 10^4^ copies of divergent target (Div4). Lanes 5, 10 and 15: no template control (NTC). The 50 bp (left) and 25 bp (right) DNA ladder. Staining is with ethidium bromide. (**B**) Real-time PCR curves show the amplification of standard primer, 3H-, 4H- and 4K-primer targeting on WT or divergent (Div4) consensus targets. Amplification efficiency was monitored based on the fluorescence of EvaGreen^®^ dye at two target concentrations, 3 × 10^6^ copies (Hi) or 3 × 10^4^ copies (Lo) per assay. NTC indicates no template control. All curves represent three replicates. (**C**) Performance of purine biversal (3H, 4H and 4K) primers by *C*~t~. Black: amplification of standard primer (Std) on WT and divergent (Div4) targets at high (Hi) or low (Lo) concentrations. Yellow: amplification of 3H-primer on WT and Div4 targets at both target concentrations. Magenta and Cyan bars indicate performances of 4H- and 4K-primers (all primers were 1 μM). (**D**) Performance evaluation of purine analog (4I and 4H) primers by *C*~t~. Black bars: Standard primer (Std) on WT and divergent (Div4) targets at higher (Hi) or lower (Lo) target concentration. Cyan: The amplification of 4I-primer on WT and Div4 targets at Hi or Lo target concentration. Magenta bars: The performance of 4H-primers. All primers were 0.5 μM.](gky392fig3){#F3}

For standard primers, signal threshold was passed after 6.7 cycles (Figure [3C](#F3){ref-type="fig"}); the target with four A:C mismatches required 12.1 cycles at high target concentrations (Div4-Hi, Figure [3C](#F3){ref-type="fig"}). With target at lower concentrations, the mismatched primer was also less efficient. This showed clearly the value of biversality.

With both **H** and **K** at high and low target concentrations, amplification rates were essentially identical (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}). Paralleling the higher affinity of **K** for T over C, the *C*~t~ values were 6.3 and 6.8 at high target concentrations, and 14.6 and 15.0 at low target concentrations (4K, Figure [3C](#F3){ref-type="fig"}). The Δ*C*~t~ here is 0.4--0.5. Interestingly, the greater preference of **H** for T versus C was not manifested in the amplification efficiencies. The *C*~t~ values were 6.6 and 7.2 at high target with three **H**'s, and 6.4 and 7.1 with four **H**'s. The corresponding numbers at low target with three **H**'s were 14.8 and 15.4, versus 14.7 and 15.4 with four **H**'s (3H and 4H, Figure [3C](#F3){ref-type="fig"}).

Also interesting, the fluorescence of EvaGreen bound to products from **H**- and **K**-containing primers is 30--50% of that from standard primers (Figure [3B](#F3){ref-type="fig"}). However, the PCR amplicons from each assay showed almost the same intensity by agarose gel/ethidium bromide analysis (Figure [3A](#F3){ref-type="fig"}). This suggests that EvaGreen intercalates less well in a duplex containing biversals, is intrinsically less fluorescent upon binding, or has its fluorescence quenched.

Amplification curves from **K**-containing primers showed abnormal shapes (Figure [3B](#F3){ref-type="fig"}). This might be due to incorporation of both dTTP and dCTP opposite **K**, producing amplicon mixtures with **K** variously paired with T or C. In contrast, since **H** directs incorporation of primarily dTTP, later amplifications with the **H**-containing primer may be better. This is consistent with amplification curves, more sigmoidal with **H** than **K** (Figure [3B](#F3){ref-type="fig"}).

Primers containing **H** were next compared with primers containing inosine (**I**) (Figure [3D](#F3){ref-type="fig"}), relative to standard primers. All PCR conditions were the same (Figure [3B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"}), except that primer concentrations were reduced to 0.5 μM and polymerase concentrations were reduced to 0.05 unit/μl. Further, uracil-DNA glycosylase (UDG, NEB) and a mixture of dUTP/dTTP were added into PCR to prevent carry-over contamination.

Amplification of all targets was slower (Figure [3D](#F3){ref-type="fig"}), reflecting lower concentrations of primers and polymerase. For **H**-primers, *C*~t~ values were 7.8 and 10.3 cycles (WT-Hi and Div4-Hi, Figure [3D](#F3){ref-type="fig"}). *C*~t~ values were worse (16.8 and 19.0 cycles) for WT and divergent targets (WT-Lo and Div4-Lo, Figure [3D](#F3){ref-type="fig"}). Δ*C*~t~ values were 2.5 and 2.2 for WT and divergent targets at high and low concentrations (4H, Figure [3D](#F3){ref-type="fig"}).

For **I**-primers, *C*~t~ values for the divergent target (**I** pairs C) were 9.1 and 14.6 at high and low target concentrations (Figure [3D](#F3){ref-type="fig"} and [Supplementary Figure S3a](#sup1){ref-type="supplementary-material"}). However, *C*~t~ values for WT target (**I** pairs T) were 12.2 and 22.9 cycles, with Δ*C*~t~ values of 3.1 and 8.3 at high and low concentrations (4**I**, Figure [3D](#F3){ref-type="fig"}). This corresponds to the *T*~m~ preference of **I** with C. For standard primers, Δ*C*~t~ between matched and mismatched targets were 11.2 and 7.3 cycles. Overall, the **H**-containing primers had smaller Δ*C*~t~ differences between WT and divergent targets than standard and **I**-containing primers (Figure [3D](#F3){ref-type="fig"}), showing an advantage of **H**.

To test the combination of biversal **H** and **P** in primers to manage sequence divergence, standard and **H** and **P**-primers were tested to amplify WT (HIV-1C consensus) and divergent targets (four or six mutations in primer binding segments). As expected, **H** and **P**-containing primers can amplify all targets and provide more uniform amplification than the standard primers ([Supplementary Figure S3b](#sup1){ref-type="supplementary-material"}).

In addition, *T*~m~s of amplicons from 1 μM of Std-, 3**H**-, 4**H**- and 4**K**-containing primers were 79.2, 79.4, 79.6 and 75.0°C. *T*~m~s of the amplicons from 0.5 μM of Std-, 4**H**- and 4**I**-containing primers and dUTP/dTTP mixture were 78.4, 78.6 and 77.3°C. The *T*~m~s of amplicons from standard primers and **H**-primers were almost identical, and higher than amplicons from **I**- and **K**-containing primers. *T*~m~s of these purine analog-containing amplicons also agreed with the melting temperature studies in Table [1](#tbl1){ref-type="table"}.

Management of sequence divergence in SNP analysis {#SEC3-5}
-------------------------------------------------

We then asked if the biversal-containing probes worked in ligation assays to detect medically significant SNPs with mutations nearby. This is especially a problem when seeking drug resistance in rapidly evolving RNA viruses. For example, the SNP in HIV reverse transcriptase that confers resistance to common drugs lies between sites that rapidly diverge in the coding region. These uninteresting SNPs confound efforts to detect the relevant SNPs in standard architectures that use standard nucleobases.

Ligation probes were designed with different numbers of **H** and **K** biversals (Table [3](#tbl3){ref-type="table"}). WT target (WT-g) was chosen from the consensus sequence of the RT gene of HIV-1B; the divergent targets (Div2 and Div3) have either two or three mutations near the ligation site. Here, the medically irrelevant SNPs replaced C by T.

Three **H** or **K** biversals were put in the acceptor probes, and two or four biversals were put in the donor probes, to pair with sites holding mutations in the targets. The efficiency of ligations was compared with standard probe ligations on WT target (Figure [4](#F4){ref-type="fig"}). As seen in Figure [4](#F4){ref-type="fig"} (left, lanes 1 and 7), standard probes gave ∼50% ligation product with the perfectly matched WT target (WT-g). In contrast, the same probes produced no ligation product at all with divergent targets (Div2 and Div3) that had two or three nearby medically irrelevant mismatches (Figure [4](#F4){ref-type="fig"}, left, lanes 2 and 8).

![Ligation of standard probes and purine analog (K-, H- and I-containing) probes on wild-type (WT-g) or divergent (Div2 and Div3) targets. Acceptor probes were 5′-^32^P labeled, ligation assays were resolved on PAGE gel (20% with 7 M urea). Lanes 1, 2, 7 and 8 (left gel): Standard probes were ligated on wild-type (WT-g) or divergent targets (Div2 and Div3). Lanes 3, 4, 9 and 10 (left gel): Biversal K-probes were used. Lanes 5, 6, 11, 12 (left gel) and 1, 2 and 3 (right gel): Biversal H-probes were used. Lanes 4, 5 and 6 (right gel): I-containing probes were used.](gky392fig4){#F4}

Here, biversality implemented via tautomerism has a large and potentially useful impact. For 2**K**-donor probes containing two **K**'s to match medically irrelevant SNPs, ∼50% ligation was seen for both targets WT-g and Div2. With the 4**K**-donor probe, ligation products decreased to ∼30% for WT target and further for the divergent target (Figure [4](#F4){ref-type="fig"}, lanes 9 and 10). The decreased ligation may be caused by the lower T~m~ of **K**:C and **K**:T pairs relative to the A:T pair; alternatively, the freely rotating OMe group of biversal **K** may disturb the double helix structure of the ligation probe and target, a disturbance recognized by the ligase enzyme. For **H**-containing probes, results were markedly better. Ligation products were produced for all targets at 50% levels. Further, the medically irrelevant mutations in the divergent targets had no significant impact on ligation efficiency for the 4**H**-containing probes (Figure [4](#F4){ref-type="fig"}, left, lanes 5, 6, 11 and 12).

Next, **H** in the ligation probes was replaced with inosine (**I**). Inosine-containing probes failed to ligate on the wild-type (WT-g) and divergent (Div2) targets (Figure [4](#F4){ref-type="fig"}, right, lanes 4 and 5), and made negligible product on Div3 (Figure [4](#F4){ref-type="fig"}, right, lane 6). In contrast, **H**-probes successfully produced products for all targets (Figure [4](#F4){ref-type="fig"}, right, lanes 1--3). This shows another advantage of **H** over **I**.

To detect SNPs in variable targets in a ligation assay, standard probes can detect only perfectly matched targets (Table [4](#tbl4){ref-type="table"}, Wt-C, Figure [5](#F5){ref-type="fig"}, lane 1). As expected, standard probes generated no ligation products with targets having single C to T mutations directly at the ligation sites (Mut-T, Div-T, Figure [5](#F5){ref-type="fig"}, lanes 2 and 4). However, they also failed with a matching at the exact ligation site if that site had flanking mismatches (Div-C) (Figure [5](#F5){ref-type="fig"}, lane 3).

![SNP detection by ligation of standard and biversal H- and K-probes on wild-type (WT-C) or mutant (Mut-T, Div-C, Div-T) targets. Acceptor probes 5′-^32^P labeled; products resolved on PAGE gel (20%, 7 M urea). Lanes 1, 2, 3 and 4: Ligation using standard probes on WT or mutation targets. Lanes 5, 6, 7 and 8: with **H**-probes. Lanes 9, 10, 11 and 12: with **K**-probes. A 10-bp DNA ladder (right).](gky392fig5){#F5}

This failure was not seen with probes containing **H** and **K**. These not only ligate when held by perfectly matched targets (WT-C, Figure [5](#F5){ref-type="fig"}, lanes 5 and 9), but also with mutations flanking that site (Div-C, Figure [5](#F5){ref-type="fig"}, lanes 7 and 11). **H**- and **K**-containing probes also differentiate a medically relevant C to T change at the ligation site, regardless of the presence of nearby medically irrelevant SNPs (Mut-T, Div-T, Figure [5](#F5){ref-type="fig"}, lanes 6, 8, 10 and 12).

We also asked whether the second-generation biversal pyrimidine (**Figure [1](#F1){ref-type="fig"}**) could allow medically relevant SNPs to be detected using ligation probes with **P** at the positions where A←→G transition mutations were found ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). **P**-containing probes generated equal amount of product for all targets (a-WT, Div5 and Div6) ([Supplementary Figure S4a](#sup1){ref-type="supplementary-material"}). This shows, as with **K** and **H**, that **P**-containing probes accommodate one or two mutations in regions flanking an interesting site. Standard probes failed to give ligation product if two mismatches (T:G) were present in the flanking region with two A to G mutations ([Supplementary Figure S4a](#sup1){ref-type="supplementary-material"}, lane 3). Likewise, probes where **I** replaces **P** also failed to give products when two transition mutations (A to G) were in the flanking region and caused two **I**:G mismatches (data not shown). For the SNP detection, biversal **P**-containing probes performed nearly identically as the standard probes to differentiate medically relevant SNP changes ([Supplementary Figure S4b](#sup1){ref-type="supplementary-material"}).

CONCLUSION {#SEC4}
==========

The 'concept' behind Brown's biversal pyrimidine nucleobase is based on the addition of an oxygen atom to the exocyclic amino group of base to shift the imine-enamine tautomeric equilibrium (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) ([@B27]). Thermal denaturation experiment of DNA with Brown\'s pyrimidine biversal nucleosides showed that the 'tied-back' bicyclic version was much better than N6-methoxycytidine, perhaps for steric reasons. Brown, however, was unable to make a tied-back version of the purine biversal.

The successful synthesis of the 'tied back' tricyclic purine oxime reported here allows, for the first time, extensive evaluation of the 'oxime tautomerism' strategy to create biversality. Overall, the strategy is successful. **H**-containing primers perform as well as perfectly matched standard primers in PCR. They work better than standard primers that are mismatched against mutated targets (by approximately five cycles with multiple mismatches). This **H** allows more uniform amplification of perfectly matched targets and mutated targets in an evolved virus.

However, by thermodynamic measurements, the added ring in **H** appears to perturb its tautomeric ratio in favor of the **H**:T match over the **H**:C match. This perturbation is reflected in enzymatic pairing with template **H**, making it behave more like A. This may be useful in PCR amplification, as the preference for **H**:T matches allows ambiguity in targets to be 'resolved' in amplicons in favor of T.

Primers containing **H** performed competitively with the universal base inosine (**I**) in many contexts. However, **H** performed better in ligation assays. We expect this to be its principal application over inosine. **H** may also be adapted to Taqman-like assays ([@B28]), where small numbers of mismatches have large impacts on the outcome.

Single oligonucleotide probes that match ambiguous sites with 'universal bases' or 'biversal bases' could also replace mixed primers. They might also replace consensus primers that overlook the divergence in the initial PCR priming step, as in PANDAA (Pan Degenerate Amplification and Adaptation) to detect HIV drug-resistance ([@B29]). Biversal base-containing primers and probes can also be used in isothermal amplification and other genotyping assays to detect medically relevant SNPs at sites flanked by irrelevant variation.
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